Fady Boctor

Fady Boctor discloses dealings in Petros Pharmaceuticals, Inc. to SEC (Form 4). We count 4 filings; the first trade dates from 21 December 2023 and the latest from 5 June 2026.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 5 June 2026, the filings show a share grant in Petros Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.